Search

everythinglearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Some drugs used to treat inflammation may cause hair loss.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

A new compound shows promise as a topical treatment for hair loss.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Tislelizumab can cause cutaneous lupus erythematosus.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Upadacitinib may effectively treat resistant lichen planopilaris.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.